Laboratory readiness and genomic surveillance of Covid-19 in the capital of Brazil.

This study aims to analyze the diagnostic readiness to Covid-19 and the genomic surveillance of SARS-CoV-2 in Brasília, the capital of Brazil. This is a retrospective, cross-sectional study, with data from: cases/deaths-Ministry of Health; RT-PCR analyses Brasília Central Public Health Laboratory (L...

Full description

Saved in:
Bibliographic Details
Main Authors: Fabrício Vieira Cavalcante, Christina Pacheco Santos Martin, Gustavo Saraiva Frio, Rodrigo Guerino Stabeli, Leonor Maria Pacheco Santos
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLOS Global Public Health
Online Access:https://doi.org/10.1371/journal.pgph.0003289
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841533099109777408
author Fabrício Vieira Cavalcante
Christina Pacheco Santos Martin
Gustavo Saraiva Frio
Rodrigo Guerino Stabeli
Leonor Maria Pacheco Santos
author_facet Fabrício Vieira Cavalcante
Christina Pacheco Santos Martin
Gustavo Saraiva Frio
Rodrigo Guerino Stabeli
Leonor Maria Pacheco Santos
author_sort Fabrício Vieira Cavalcante
collection DOAJ
description This study aims to analyze the diagnostic readiness to Covid-19 and the genomic surveillance of SARS-CoV-2 in Brasília, the capital of Brazil. This is a retrospective, cross-sectional study, with data from: cases/deaths-Ministry of Health; RT-PCR analyses Brasília Central Public Health Laboratory (LACEN); genomics-Global Initiative on Sharing All Influenza Data (GISAID). It was found that in March 2021, with the Gamma variant was predominant, RT-PCR diagnostic tests administered by LACEN reached their peak, followed by a reduction, possibly due to the start of vaccination. New peaks were observed in September 2021 and January 2022. The average time for releasing RT-PCR results was reduced from eight days (July 2020), to around eight hours in 2023. The participation of private laboratories was evident in sequencing the SARS-CoV-2 variants of concern in Brasília (n = 1,897). LACEN sequenced 50% of the samples received (571). A decrease in the incidence of cases and deaths due to Covid-19 was noted in the years 2022 to 2023, following the national trend. LACEN maintained RT-PCR diagnostic tests administered satisfactorily throughout the period. Regarding the genomic surveillance of SARS-CoV-2, the vast majority of samples were sequenced by private laboratories when compared to the public laboratory.
format Article
id doaj-art-8156f996fbe24f0ba130922a9769a547
institution Kabale University
issn 2767-3375
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLOS Global Public Health
spelling doaj-art-8156f996fbe24f0ba130922a9769a5472025-01-17T05:49:09ZengPublic Library of Science (PLoS)PLOS Global Public Health2767-33752025-01-0151e000328910.1371/journal.pgph.0003289Laboratory readiness and genomic surveillance of Covid-19 in the capital of Brazil.Fabrício Vieira CavalcanteChristina Pacheco Santos MartinGustavo Saraiva FrioRodrigo Guerino StabeliLeonor Maria Pacheco SantosThis study aims to analyze the diagnostic readiness to Covid-19 and the genomic surveillance of SARS-CoV-2 in Brasília, the capital of Brazil. This is a retrospective, cross-sectional study, with data from: cases/deaths-Ministry of Health; RT-PCR analyses Brasília Central Public Health Laboratory (LACEN); genomics-Global Initiative on Sharing All Influenza Data (GISAID). It was found that in March 2021, with the Gamma variant was predominant, RT-PCR diagnostic tests administered by LACEN reached their peak, followed by a reduction, possibly due to the start of vaccination. New peaks were observed in September 2021 and January 2022. The average time for releasing RT-PCR results was reduced from eight days (July 2020), to around eight hours in 2023. The participation of private laboratories was evident in sequencing the SARS-CoV-2 variants of concern in Brasília (n = 1,897). LACEN sequenced 50% of the samples received (571). A decrease in the incidence of cases and deaths due to Covid-19 was noted in the years 2022 to 2023, following the national trend. LACEN maintained RT-PCR diagnostic tests administered satisfactorily throughout the period. Regarding the genomic surveillance of SARS-CoV-2, the vast majority of samples were sequenced by private laboratories when compared to the public laboratory.https://doi.org/10.1371/journal.pgph.0003289
spellingShingle Fabrício Vieira Cavalcante
Christina Pacheco Santos Martin
Gustavo Saraiva Frio
Rodrigo Guerino Stabeli
Leonor Maria Pacheco Santos
Laboratory readiness and genomic surveillance of Covid-19 in the capital of Brazil.
PLOS Global Public Health
title Laboratory readiness and genomic surveillance of Covid-19 in the capital of Brazil.
title_full Laboratory readiness and genomic surveillance of Covid-19 in the capital of Brazil.
title_fullStr Laboratory readiness and genomic surveillance of Covid-19 in the capital of Brazil.
title_full_unstemmed Laboratory readiness and genomic surveillance of Covid-19 in the capital of Brazil.
title_short Laboratory readiness and genomic surveillance of Covid-19 in the capital of Brazil.
title_sort laboratory readiness and genomic surveillance of covid 19 in the capital of brazil
url https://doi.org/10.1371/journal.pgph.0003289
work_keys_str_mv AT fabriciovieiracavalcante laboratoryreadinessandgenomicsurveillanceofcovid19inthecapitalofbrazil
AT christinapachecosantosmartin laboratoryreadinessandgenomicsurveillanceofcovid19inthecapitalofbrazil
AT gustavosaraivafrio laboratoryreadinessandgenomicsurveillanceofcovid19inthecapitalofbrazil
AT rodrigoguerinostabeli laboratoryreadinessandgenomicsurveillanceofcovid19inthecapitalofbrazil
AT leonormariapachecosantos laboratoryreadinessandgenomicsurveillanceofcovid19inthecapitalofbrazil